Healthcare Industry Reports

According to the latest report by IMARC Group, titled  “ Aerosol Delivery Devices Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028, ” The global aerosol delivery devices market size reached US$ 44.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 63.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028. Aerosol delivery devices are handheld, portable drug delivery devices used in treating respiratory disorders, such as asthma, obstructive lung diseases, pulmonary infections and arterial hypertension, and cystic fibrosis. They aid in lessening dosage requirements, reducing systemic adverse effects, and improving the ability of patients to self-administer medication. At present, due to the advent of novel macromolecular medications, smart aerosol delivery devices are finding extensive application in non-respiratory conditions, such as analgesia, diabetes, and Parkinson’s disease. As the novel co

According to the latest report by IMARC Group, titled  “Onychomycosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028, ” offers a comprehensive analysis of the industry, which comprises insights on the onychomycosis treatment market size . The global onychomycosis treatment market size reached US$ 3.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.37% during 2023-2028. Onychomycosis refers to a fungal infection that causes discoloration, thickening, and separation of the nails. It can be treated through medications, laser therapy, and photodynamic therapies. Its treatment is usually given based on the type of fungus causing infection, the number of affected nails, and the severity of nail involvement. As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry b

According to the latest report by IMARC Group, titled  “ Nanopore Technologies Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027, ” The global nanopore technologies market reached a value of US$ 213.8 Million in 2021. Looking forward, IMARC Group expects the market to reach   US$ 476.6 Million by   2027, exhibiting at a CAGR of 13.7 %  during 2022-2027. Nanopore technologies enable direct, real-time analysis of long deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) fragments. They help resolve complex structural variants and repetitive regions. They also offer low-cost genotyping, high mobility for testing and throughput, and fast processing of samples in real-time. Consequently, nanopore technologies are widely used as a diagnostic tool to provide rapid analysis, detect target molecules, and eliminate cumbersome amplification and conversion steps. As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking